Associate Director, Project Management (Late Stage/Commercialization)
MBX Biosciences
This listing was originally posted on MBX Biosciences's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moPosition Summary
The Associate Director (AD), Project Management is responsible for leading complex, high-impact asset programs and enterprise initiatives across the full product lifecycle—from discovery and development through late-stage development, launch readiness, and commercialization. This role ensures alignment with organizational strategy, portfolio priorities, and value creation objectives.
The AD will partner closely with and co-lead strategic planning, scenario analysis, and critical decision-making with the Project Leads (DT/ADT/ACT Leads) and senior functional leaders. Reporting to the Head of Portfolio and Project Management, the AD provides strategic leadership, governance, and executional excellence, ensuring cross-functional teams operate effectively, decisions are data-driven, and programs advance in accordance with the MBX operating model.
This role requires a seasoned leader with strong enterprise mindset, exceptional communication and influencing skills, and the ability to guide cross-functional teams in a fast-paced, evolving environment.
Key Responsibilities
Education & Qualifications
Travel
You will be expected to travel periodically based on the needs of the business to the extent requested by the Company including attendance at Together Weeks, Together Days and functional meetings as requested by the Company.
Company Overview:
MBX Biosciences, Inc. (NASDAQ: MBX) is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The Company was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, the Company designed its proprietary Precision Endocrine Peptide™ (PEP™) platform to overcome the key limitations of unmodified and modified peptide therapies and to improve clinical outcomes and simplify disease management for patients. PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company’s pipeline includes its lead product candidate MBX 2109, in Phase 2 development for the treatment of chronic hypoparathyroidism (HP); MBX 1416, in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH); and an obesity portfolio that includes MBX 4291, as well as multiple discovery and pre-clinical candidates in development for the treatment of obesity. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at www.mbxbio.com and follow us on LinkedIn.
EEO Statement:
MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at MBX Biosciences?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Hormone Analogues for Rare Endocrine Diseases
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo